We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
Consensus vs. actual, and revenue trend
| 분기 | 발표일 | 시각 | EPS 예상 | EPS 실제 | 서프라이즈 | 매출 예상 | 매출 실제 | 상태 |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 08. 06. | 장 마감 후 (AMC) | $1.43 | — | — | $245.24M | — | 예정 |
| FY2026 Q1 | 2025. 03. 31. | 시각 미정 | — | $-4.38 | — | — | $231.33M | 보고됨 |
| FY2025 Q3 | 2024. 09. 30. | 시각 미정 | — | $-93.43 | — | — | $698.48M |
Consensus PT $43.6 · 5 analysts
| 날짜 | 리서치펌 | 애널리스트 | 액션 | 의견 변화 | 목표가 | 리포트 |
|---|---|---|---|---|---|---|
| 2026. 05. 29. | Canaccord Genuity | — | 커버리지 개시 | — → Buy | — | Canaccord Genuity: Buy |
| 2026. 04. 24. | Barclays | — | 커버리지 개시 | — → Overweight | — | Barclays: Overweight |
동일 리서치펌의 과거 의견 변화, 동일 섹터 내 다른 종목 액션과 비교 가능
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
| 보고됨 |
| FY2025 Q2 | 2024. 06. 30. | 시각 미정 | — | $-69.18 | — | — | $467.98M | 보고됨 |
Automated summary from public sources · not investment advice
공시·실적·기관 변화를 한국어 한 단락으로 요약. 원문 출처와 함께 제공됩니다.
Ranked by position value
| # | 기관 | 운용 형태 | 보유 주식 | 평가액 | 비중 | 변화율 | 포지션 |
|---|---|---|---|---|---|---|---|
| 1 | Point72 Asset Management, L.P. | Point72 Asset Management, L.P. | 68,217 | $2.92B | 0.00% | — | 신규 편입 |
| 2 | Point72 Asset Management, L.P. | Point72 Asset Management, L.P. | 89,444 | $1.46B | 0.00% | — | 신규 편입 |
신규 편입·전량 매도·비중 변화까지 모두 확인할 수 있습니다.
Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers claims intelligence solutions, including reference-based pricing, negotiation services, surprise bill services, and Vistara; network solutions, such as primary networks, complementary networks, and network build and network management services; and payment and revenue integrity solutions comprising clinical negotiation, pre-payment integrity, post-payment integrity, and revenue integrity services. It also provides data and analytics solutions consists of PlanOptix, CompleteVue, BenInsights, risk scores, and supplemental carrier services. The company provides solutions to commercial healthcare payers, third party administrators, employers, brokers/consultants, providers, government healthcare payers and system integrators. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, property and casualty insurers, bill review companies and other companies involved in the claims adjudication process. The company was formerly known as MultiPlan Corporation and changed its name to Claritev Corporation in February 2025. Claritev Corporation was founded in 1980 and is headquartered in McLean, Virginia.
Stored first · Google News · Yahoo Finance (English)
Claritev Q1 2026 Earnings Call Transcript - Benzinga
Claritev Q1 2026 Earnings Call Transcript Benzinga
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Claritev Corporation (CTEV) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Claritev Corporation (CTEV) and Encourages Shareholders to Learn More About the Investigation ACCESS Newswire
2026-05-31 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Claritev Corporation (CTEV) and Encourages Shareholders to Learn More About the Investigation | NYSE:CTEV | Press Release - Stockhouse
2026-05-31 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Claritev Corporation (CTEV) and Encourages Shareholders to Learn More About the Investigation | NYSE:CTEV | Press Release Stockhouse
Claritev (CTEV) Q1 2026 Earnings Transcript - AOL.com
Claritev (CTEV) Q1 2026 Earnings Transcript AOL.com
Claritev (CTEV) Receives Buy Rating and $32 Target from Canaccor - GuruFocus
Claritev (CTEV) Receives Buy Rating and $32 Target from Canaccor GuruFocus
CCORF Initiates Claritev(CTEV.US) With Buy Rating, Announces Target Price $32 - 富途牛牛
CCORF Initiates Claritev(CTEV.US) With Buy Rating, Announces Target Price $32 富途牛牛